IgM+ memory B cells serve as indicators of patient response to Nivolumab monotherapy in melanoma.78 In breast cancer, the atlas of infiltrated B cells revealed a higher proportion of B cells within tumor-associated TLSs, predominantly memory B cells, compared to the naive B cells in peripheral blood. The gene discussed is CD40LG; the disease is neoplasm.